3ZY1
Crystal structure of the human p63 tetramerization domain
Experimental procedure
Experimental method | MAD |
Source type | SYNCHROTRON |
Source details | DIAMOND BEAMLINE I03 |
Synchrotron site | Diamond |
Beamline | I03 |
Temperature [K] | 100 |
Detector technology | CCD |
Detector | ADSC CCD |
Spacegroup name | P 4 2 2 |
Unit cell lengths | 58.198, 58.198, 39.328 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 58.200 - 2.150 |
R-factor | 0.23793 |
Rwork | 0.236 |
R-free | 0.28517 |
Structure solution method | MAD |
Starting model (for MR) | NONE |
RMSD bond length | 0.012 |
RMSD bond angle | 1.354 |
Refinement software | REFMAC (5.6.0116) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 58.200 | 2.270 |
High resolution limit [Å] | 2.150 | 2.150 |
Rmerge | 0.050 | 0.800 |
Number of reflections | 3966 | |
<I/σ(I)> | 23.7 | 3.3 |
Completeness [%] | 99.4 | 99.8 |
Redundancy | 9.4 | 9.7 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 290 | SITTING DROP VAPOR DIFFUSION AT 17 DEGREE C. PROTEIN SOLUTION: 12-15 MG/ML IN 20 MM TRIS PH 8.5, 50 MM NACL CRYSTALLIZATION BUFFER: 10% PEG 8000, 0.1 M HEPES PH 7.5, AND 0.2 M CA ACETATE |